Articles
UPS eyes precision logistics for health-care push
UPS is banking on “precision logistics” to be a major component of its health-care push. The Wall Street Journal reports United Parcel Service Inc. (NYSE: UPS) will debut “early next year” its real-time tracking service of medical packages that uses a combination of high-powered sensors that interact with Bluetooth, cellular and Wi-Fi technologies, and data analytics. The…
Read MoreCareers in Life Sciences Video interview: Meet Tyler Thompson, Quality Assurance Administrator at ArunA Bio
Enjoy this brief interview with Tyler Thompson, Quality Assurance Administrator at ArunA Bio. Thompson received a Bachelor’s degree in Education and Biology as well as a Master’s degree in Ecology and Evolutionary Biology from Bowling Green State University. Dendreon is a commercial-stage biopharmaceutical company and a pioneer in the development of immunotherapy. For over twelve…
Read MoreTakeda plans 65% increase in plasma manufacturing capacity
Takeda commits to 65% increase in plasma manufacturing capacity to support business acquired in takeover of Shire. Shire grew into a leader in plasma-derived therapies through its $32bn takeover of Baxalta, the Baxter spinoff that had a portfolio of such products and the infrastructure to manufacture them. Takeda took control of those assets at the…
Read MoreSpeaker Pelosi’s Drug Pricing Plan Could Result in 56 Fewer New Medicines Over 10 Years
Washington, D.C. (November 21, 2019) — Speaker Nancy Pelosi’s Lower Drug Costs Now Act of 2019, H.R.3, could result in at least 56 fewer new medicines for patients over 10 years, according to a new analysisfrom economic consulting firm Vital Transformation. The study examined the impact of foreign reference pricing provisions in H.R.3 on treatments and cures from…
Read MoreMeet Ricky Lowe, Manager of Bioinformatics & Data Management at AKESOgen, Inc.
Enjoy this interview with Ricky Lowe, Manager of Bioinformatics & Data Management at AKESOgen, Inc. Lowe graduated from the University of Georgia with Bachelor’s degrees in Biology and English, and later went on to earn a Master’s degree in Biotechnology & Bioinformatics from Johns Hopkins University. AKESOgen is a biomarker, genomics, and pharmacogenomics CRO company…
Read MoreSeven appointed to Georgia commission overseeing new medical marijuana program
Georgia’s rollout of legislation legalizing the growth of marijuana for medicinal use and the manufacture and sale of cannabis oil produced from the leaf crop can now begin, more than four months after the law took effect. Gov. Brian Kemp has named Dr. Christopher Edwards, principal surgeon at the Atlanta Neurological & Spine Institute, to chair…
Read MoreGeoVax Vaccine Selected to Participate in Development of Potential HIV Functional Cure
Clinical Trial Expected to Commence in Early 2020 ATLANTA, GA, November 13, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX) announced today its participation in a collaborative effort led by researchers at the University of California, San Francisco (UCSF), to develop a combinational therapy aimed at inducing remission in HIV-positive individuals (a “functional cure”). The studies will be…
Read MoreCovanos Named Platinum Winner At Cleveland Clinic’s 2019 Medical Innovation Summit AMP’D Arena Competition
ATLANTA, Oct. 31, 2019 /PRNewswire/ — Covanos, Inc., an Atlanta-based private medical technology company, was named the Platinum Winner of the AMP’D Arena Pitch Competition at the 2019 Medical Innovation Summit, organized by Cleveland Clinic and co-sponsored by the Wallace H. Coulter Foundation. The Company’s first product-in-development, C-HEART is a PC-based software product that uses proprietary advances in…
Read MoreClearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery
ALPHARETTA, Ga., Oct. 30, 2019 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that REGENXBIO Inc. (Nasdaq: RGNX) has exercised its option under the previously announced option and license agreement to…
Read MoreGeorgia Bio Statement on BD Sterilization Plant In Georgia
Closure May Lead to Medical Device Shortage & Impact Patients October 25, 2019 06:06 PM Eastern Daylight Time ATLANTA–(BUSINESS WIRE)–Georgia Bio member companies are dedicated to improving patients’ lives-enhancing patient safety and expanding patient access to innovative treatments. Public health and environmental protection are central to the values of the life sciences community. Our member…
Read More